| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.006 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |